Brevan Howard Capital Management LP Codexis, Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Codexis, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 48,734 shares of CDXS stock, worth $80,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,734
Previous 42,029
15.95%
Holding current value
$80,411
Previous $102,000
15.69%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
68.3MCall Options Held
42KPut Options Held
31.8K-
Opaleye Management Inc. Boston, MA12.8MShares$21.1 Million5.2% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$7.71 Million0.0% of portfolio
-
Abrdn PLC4.09MShares$6.75 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.07MShares$6.71 Million0.0% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $108M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...